Skip to main content
Year archive

3SBio Inc. — 2025 filings

All 78 regulatory filings released by 3SBio Inc. (1530) in 2025, sourced directly from the official regulator.

78 Filings
2025 Period
2025 filings (78)
Filing Released Lang
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-12-09 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-12-09 English
TERMS OF REFERENCE OF NOMINATION COMMITTEE
Governance Information
2025-12-09 English
TERMS OF REFERENCE OF AUDIT COMMITTEE
Governance Information
2025-12-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Share Issue/Capital Change
2025-12-03 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-12-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2025
Share Issue/Capital Change
2025-12-01 English
PROPOSED SPIN-OFF AND SEPARATE LISTING OF MANDI INC. ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED
M&A Activity
2025-11-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings
2025-11-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2025
Regulatory Filings
2025-11-03 English
CONNECTED TRANSACTION GRANT OF AWARDED SHARES BY A SUBSIDIARY OF THE COMPANY PURSUANT TO ITS EQUITY INCENTIVE PLAN
Share Issue/Capital Change
2025-10-20 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025
Regulatory Filings
2025-10-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Share Issue/Capital Change
2025-10-02 English
2025 Interim Report
Interim / Quarterly Report H1 2025
2025-09-30 English
Notification Letter and Request Form to Non-registered Holders - Notice of publication of 2025 Interim Report
Report Publication Announcement
2025-09-29 English
Letter to Registered Shareholders - Notice of publication of 2025 Interim Report
Report Publication Announcement
2025-09-29 English
2025 Interim Report
Interim / Quarterly Report H1 2025
2025-09-29 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Share Issue/Capital Change
2025-09-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings
2025-09-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025
Regulatory Filings
2025-09-01 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report H2 2025
2025-08-29 English
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report H2 2025
2025-08-28 English
NOTICE OF BOARD MEETING
Regulatory Filings
2025-08-19 English
DATE OF BOARD MEETING
Regulatory Filings
2025-08-18 English
INSIDE INFORMATION ANNOUNCEMENT / POSITIVE PROFIT ALERT
Earnings Release H2 2025
2025-08-14 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-08-01 English
COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Share Issue/Capital Change
2025-08-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2025
Share Issue/Capital Change
2025-08-01 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-07-29 English
(1) THE LICENSE AGREEMENT FOR PD-1/VEGF BISPECIFIC ANTIBODY (SSGJ-707) WITH PFIZER COMING INTO EFFECT&#x3b; AND (2) PROPOSED SUBSCRIPTION OF NEW SHARES BY PFIZER UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-07-24 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2025
Regulatory Filings
2025-07-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Regulatory Filings
2025-07-03 English
INSIDE INFORMATION ANNOUNCEMENT
Legal Proceedings Report
2025-06-30 English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE
Governance Information
2025-06-25 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2025-06-25 English
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 JUNE 2025&#x3b; (2) PAYMENT OF FINAL DIVIDEND&#x3b; AND (3) CHANGES IN COMPOSITION OF THE NOMINATION COMMITTEE
Declaration of Voting Results & Voting Rights Announcements
2025-06-25 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 23 JUNE 2025
Declaration of Voting Results & Voting Rights Announcements
2025-06-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings
2025-06-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2025
Regulatory Filings
2025-06-02 English
GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, DECLARATION AND PAYMENT OF FINAL DIVIDEND OUT OF THE SHARE PREMIUM ACCOUNT OF THE COMPANY, ADOPTION OF THE 2025 SHARE OPTION
Proxy Solicitation & Information Statement
2025-05-26 English
NOTICE OF THE ANNUAL GENERAL MEETING
AGM Information
2025-05-26 English
PROXY FORM FOR ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, 25 JUNE 2025 AT 10:00 A.M.
Proxy Solicitation & Information Statement
2025-05-26 English
Notification Letter and Request Form to Non-Registered Holders - Notice of publication of Circular in relation to proposed grant of general mandates to issue and repurchase shares, proposed re-electio
Report Publication Announcement
2025-05-22 English
Letter to Registered Shareholders - Notice of publication of (1) Circular in relation to proposed grant of general mandates to issue and repurchase shares, proposed re-election of retiring directors a
Report Publication Announcement
2025-05-22 English
FORM OF PROXY
Proxy Solicitation & Information Statement
2025-05-22 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-05-22 English
PROPOSED GRANT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-05-22 English
INSIDE INFORMATION ANNOUNCEMENT (1) ENTERING INTO LICENSE AGREEMENT FOR PD-1/VEGF BISPECIFIC ANTIBODY (SSGJ-707) WITH PFIZER&#x3b; AND (2) POSSIBLE SUBSCRIPTION OF CERTAIN NUMBER OF NEW SHARES OF
Capital/Financing Update
2025-05-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Share Issue/Capital Change
2025-05-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2025
Regulatory Filings
2025-05-02 English
Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings
2025-04-30 English
Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings
2025-04-30 English
2024 Environmental, Social and Governance Report
Environmental & Social Information
2025-04-30 English
2024 ANNUAL REPORT
Annual Report FY 2024
2025-04-30 English
Notification Letter and Request Form to Non-registered Holders - Notice of publication of 2024 Annual Report
Report Publication Announcement
2025-04-29 English
2024 Annual Report
Annual Report FY 2024
2025-04-29 English
Letter to Registered Shareholders - Notice of publication of 2024 Annual Report
Report Publication Announcement
2025-04-29 English
VOLUNTARY ANNOUNCEMENT 707 Injection (Anti-VEGF/PD-1 Bispecific Antibody) Granted Breakthrough Therapy Designation by NMPA
Regulatory Filings
2025-04-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Share Issue/Capital Change
2025-04-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2025
Regulatory Filings
2025-04-01 English
FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
Annual Report FY 2024
2025-03-28 English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
Notice of Dividend Amount
2025-03-25 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
Annual Report FY 2024
2025-03-25 English
INSIDE INFORMATION ANNOUNCEMENT / PROFIT WARNING
Regulatory Filings
2025-03-24 English
DATE OF BOARD MEETING
Regulatory Filings
2025-03-18 English
NOTICE OF BOARD MEETING
Regulatory Filings
2025-03-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Regulatory Filings
2025-03-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025
Regulatory Filings
2025-03-03 English
Letter and Reply Form to New Registered Shareholders - Election of Means of Receipt and Language of Corporate Communications
Regulatory Filings
2025-02-28 English
INSIDE INFORMATION ANNOUNCEMENT
Regulatory Filings
2025-02-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Share Issue/Capital Change
2025-02-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025
Regulatory Filings
2025-02-03 English
CHANGE OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2025-01-27 English
VOLUNTARY ANNOUNCEMENT COOPERATION BETWEEN 3SBIO INC. AND DUALITY BIOLOGICS IN RESPECT OF HER2 ADC DRUG
Regulatory Filings
2025-01-13 English
INSIDE INFORMATION - RELEASE OF CHARGE OF SHARES BY CONTROLLING SHAREHOLDER
Capital/Financing Update
2025-01-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings
2025-01-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
Regulatory Filings
2025-01-02 English